PIONEERING THE DISCOVERY AND DEVELOPMENT OF NOVEL CANCER THERAPIES
Dead / Cancelled — Cancelled — Section 8 (as of 21 Apr 2017)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77852199
- Registration number
- 3848876
- Mark type
- Stylized text
- Filed
- 19 Oct 2009
- Published for opposition
- 13 Apr 2010
- Registered
- 14 Sept 2010
- Attorney of record
- Harold Milstein
Goods and services
- Class 042 — Scientific and technological services: Research and development services in the field of pharmaceuticals; providing medical and scientific health care research information in the field of pharmaceuticals and clinical trials
- Class 044 — Medical, beauty and agricultural services: Providing health care information via telephone and the Internet; Providing information in the field of the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals
Owner
- ASTEX PHARMACEUTICALS, INC., Pleasanton, CA, US
- SuperGen, Inc., Dublin, CA, US
- SuperGen, Inc., Dublin, CA, US
- SuperGen, Inc., Dublin, CA, US
Prosecution history
- 21 Apr 2017 — CANCELLED SEC. 8 (6-YR)
- 30 Mar 2015 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Mar 2015 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 12 Oct 2011 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 14 Sept 2010 — REGISTERED-PRINCIPAL REGISTER
- 12 Aug 2010 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Aug 2010 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 11 Aug 2010 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Aug 2010 — DATA MODIFICATION COMPLETED
- 02 Aug 2010 — ASSIGNED TO LIE
- 26 Jul 2010 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Jul 2010 — USE AMENDMENT FILED
- 26 Jul 2010 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Jul 2010 — TEAS STATEMENT OF USE RECEIVED
- 08 Jun 2010 — NOA MAILED - SOU REQUIRED FROM APPLICANT